EGFR and breast cancer: The Ca2+-activated Cl− channel ANO1 facilitates the progression of breast cancer by triggering the activation of EGFR (epidermal growth factor receptor) and CAMK (calcium/calmodulin-dependent protein kinase) signaling pathways (Qu et al., 2014).